Attie A D, Pittman R C, Watanabe Y, Steinberg D
J Biol Chem. 1981 Oct 10;256(19):9789-92.
We have studied hepatocytes cultured from Watanabe-heritable hyperlipidemic (WHHL) rabbits, animals that display striking elevation of plasma low density lipoprotein (LDL), spontaneous atherosclerosis, and an absence of LDL receptor activity in cultured fibroblasts. Degradation of LDL by WHHL hepatocytes differed from degradation by normal hepatocytes in several ways: 1) degradation by normal hepatocytes as a function of LDL concentration was curvilinear with a saturable component, while degradation by WHHL hepatocytes was a linear function of concentration; 2) degradation of 125I-labeled LDL by mutant cells was not decreased by excess unlabeled LDL, while degradation by normal cells was; 3) degradation of LDL by normal cells was inhibited by colchicine and chloroquine while degradation by the mutant cells was not; 4) both cell types catabolized LDL at nearly equal rates, but activity of 3-hydroxy-3-methylglutaryl-CoA reductase was suppressed only in the normal cells. These differences are analogous to those previously reported in describing the qualitatively different pathways for receptor-dependent and receptor-independent catabolism of lactosylated and native human LDL in rat hepatocytes. Thus, hepatocytes from WHHL rabbits lack LDL receptor activity. The peripheral and hepatic LDL receptors most likely are products of the same gene or depend for their activity on a single gene product.
我们研究了从渡边遗传性高脂血症(WHHL)兔培养的肝细胞,这种动物表现出血浆低密度脂蛋白(LDL)显著升高、自发性动脉粥样硬化,且培养的成纤维细胞中缺乏LDL受体活性。WHHL肝细胞对LDL的降解在几个方面与正常肝细胞不同:1)正常肝细胞对LDL的降解作为LDL浓度的函数呈曲线关系,有一个可饱和成分,而WHHL肝细胞的降解是浓度的线性函数;2)突变细胞对125I标记的LDL的降解不会因过量未标记的LDL而减少,而正常细胞的降解会减少;3)秋水仙碱和氯喹可抑制正常细胞对LDL的降解,而突变细胞的降解不受抑制;4)两种细胞类型对LDL的分解代谢速率几乎相等,但3-羟基-3-甲基戊二酰辅酶A还原酶的活性仅在正常细胞中受到抑制。这些差异类似于先前报道的大鼠肝细胞中乳糖基化和天然人LDL的受体依赖性和受体非依赖性分解代谢的定性不同途径。因此,WHHL兔的肝细胞缺乏LDL受体活性。外周和肝脏的LDL受体很可能是同一基因的产物,或者其活性依赖于单一基因产物。